Target Price | $3.24 |
Price | $0.17 |
Potential |
1,800.16%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target IN8bio Inc 2026 .
The average IN8bio Inc target price is $3.24.
This is
1,800.16%
register free of charge
$7.50
4,296.25%
register free of charge
$1.20
603.40%
register free of charge
|
|
A rating was issued by 5 analysts: 5 Analysts recommend IN8bio Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the IN8bio Inc stock has an average upside potential 2026 of
1,800.16%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.57 | -0.21 |
43.00% | 63.16% | |
P/E | negative |
2 Analysts have issued a IN8bio Inc forecast for earnings per share. The average IN8bio Inc EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 14 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
Jones Trading |
Locked
➜
Locked
|
Locked | Feb 11 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 26 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 14 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 12 2025 |
Locked
Jones Trading:
Locked
➜
Locked
|
Feb 11 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 26 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 13 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.